Drugs Made In America Acquisition (DMAA) Return on Assets (2025)
Drugs Made In America Acquisition filings provide 1 years of Return on Assets readings, the most recent being 0.0% for Q4 2025.
- Quarterly Return on Assets changed N/A to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.0% for FY2025, N/A changed from the prior year.
- Return on Assets hit 0.0% in Q4 2025 for Drugs Made In America Acquisition, up from 0.0% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q4 2025 and bottomed at 0.0% in Q3 2025.